Answers are grounded in this paper and cite their sources.
Whether rifampin benefits retained staphylococcal prosthetic joint infection is unsettled. In a meta-analysis of 8 studies, we found greater clinical cure with fluoroquinolone-rifampin vs all other regimens (odds ratio [OR], 2.68; 95% CI, 1.43-5.02), but no greater cure with other rifampin combinations vs regimens without rifampin (OR, 1.22; 95% CI, 0.79-1.88).
No takes yet. Share an insight, caveat, or question.
Cortés-Penfield et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: